“Nanoparticle Drug Delivery Market & Clinical Pipeline Insight” Report Highlights:  Nanoparticle Drug Delivery Market Overview  Nanoparticle Drug Delivery Mechanism  Clinical Pipeline by Phase & Target Indications  Drug Profiles in Report: 190  Majority of Nanoparticle Drug in Preclinical Phase: 70  Marketed Nanoparticle Drugs: 12  Suspended & Discontinued Drug Profiles

1. Nanoparticle Drug Delivery Market To Treble by 2020
Nanoparticle drug deliver market will surpass USD 40 Billion by 2020
“Nanoparticle Drug Delivery Market & Clinical Pipeline Insight” Report Highlights:
 Nanoparticle Drug Delivery Market Overview
 Nanoparticle Drug Delivery Mechanism
 Clinical Pipeline by Phase & Target Indications
 Drug Profiles in Report: 190
 Majority of Nanoparticle Drug in Preclinical Phase: 70
 Marketed Nanoparticle Drugs: 12
 Suspended & Discontinued Drug Profiles
Technologies based on Nanoparticles are likely to bring about a revolution in the methods in
which drug delivery is achieved. These nanoparticles have been recognized as those having
the potential to improve the efficacy of drugs, reduce the expected side effects, and enable
appropriate and accurate target delivery. Thus, the drug delivery segment of the
pharmaceutical industry is likely to be impacted the most due to the increasing use of nano
technology. There is a rapid shift in the technology from polymer therapeutics to highly
innovative approaches. The use of nanoparticles in the drug delivery systems is expected to
change the horizon of medical treatment by positively impacting the economics and allowing
for improved targeting of drugs into the appropriate part of the body without side effects or
issues of toxicity. This is possible mainly because of the lower doses and increased focus on
the effect where needed. The pharmaceutical companies, in recent years have identified the
potential of nanoparticles in improving the entire process of drug delivery and thus leading to
a better level of human health and quality of life for the patients.
The combination of nanotechnology along with medicine has resulted in potential concepts
and ideas for the pharma industry which is set to introduce momentous innovations in the
fight against different diseases. The two concepts of therapeutic nanocarriers – liposomes and

2. albumin nanoparticles are gaining prominence rapidly and would soon become well-
established in the market across the globe. The need of the hour currently is to obtain a
deeper understanding of the biodistribution of nanoparticles, which is influenced mainly by
their ability to negotiate biological barriers.
For Report Sample Visit: Nanoparticle Drug Delivery Market & Clinical Pipeline Insight
Or Contact: avinash@kuickresearch.com